Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study
Aksam Yassin, Mustafa Alwani, Riadh A. Talib, Yousef Almehmadi, Joanne E. Nettleship, Khalid Al‐Rumaihi, Bassam Albaba, Daniel Kelly, Farid Saad
Abstract
). There were 25 deaths (7.8%) in the T-group of which 11 (44%) were cardiovascular related. In contrast, 28 patients (15.2%) died in C-group, and all deaths (100%) were attributed to CVD. These data suggest that long-term TTh improves hepatic steatosis and liver function in hypogonadal men. Improvements in liver function may have contributed to reduced CVD-related mortality.
Topics & Concepts
MedicineFatty liverInternal medicineSteatosisLiver functionBody mass indexProspective cohort studyGastroenterologyTestosterone (patch)WaistLiver function testsBilirubinLiver diseaseEndocrinologyDiseaseHormonal and reproductive studiesLiver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects